Nachrichten zur Hims & Hers Health Inc. Aktie

Will Hims & Hers Fall Along With Novo Nordisk?

Novo Nordisk shares are trading as low as 35% of their 52-week highs, making Hims & Hers investors nervous whether…

Hims & Hers Stock to Report Q2 Earnings: Whats in the Cards?

Hims & Hers Health, Inc. HIMS is scheduled to report second-quarter 2025 results on Aug. 4, after the closing bell.In…

HIMS LAWSUIT ALERT: Levi & Korsinsky Notifies Hims & Hers Health, Inc. Investors - Lead Plaintiff Deadline August 25, 2025

Detailed price information for Hims & Hers Health Inc (HIMS-N) from The Globe and Mail including charting and trades.…

How Will Hims & Hers Health Stock React To Its Upcoming Earnings?

Hims & Hers Health (NYSE:HIMS) is scheduled to report its earnings on Monday, August 4, 2025. Historically, HIMS stock has…

Hims & Hers Health: A Glimmer of Innovation or a Fleeting Fad?

Hims & Hers Health: A Glimmer of Innovation or a Fleeting Fad?…

Hims & Hers Health, Inc. (HIMS) – Lawmakers Urge Crackdown On Illegal Weight Loss Drugs, Novo’s Termination of Collaboration With HIMS Triggers Securities Class Actions

SAN FRANCISCO, Aug. 01, 2025 (GLOBE NEWSWIRE) -- On July 25, 2025, investors in Hims & Hers Health,…

Hims & Hers Stock Up, Nearing All-Time High As Weight-Loss Giants Stumble - Hims & Hers Health (NYSE:HIMS)

Shares of telehealth company Hims & Hers Health are up Thursday afternoon. The rally comes amid significant headwinds for major…

Hims & Hers Leads the Charge in AI-Powered Personalized Healthcare

The renowned health and wellness platform, Hims & Hers Health, Inc. HIMS, is building a next-generation, digital-first healthcare platform centered…

HIMS Investors Have Opportunity to Lead Hims & Hers Health, Inc. Securities Fraud Lawsuit with the Schall Law Firm

LOS ANGELES, July 31, 2025 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of…

HIMS Investors Have Opportunity to Lead Hims & Hers Health, Inc. Securities Fraud Lawsuit with the Schall Law Firm

/PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against…

Hims & Hers Health, Inc. Securities Fraud Class Action Lawsuit Pending: Contact The Gross Law Firm Before August 25, 2025 to Discuss Your Rights

/PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Hims & Hers Health, Inc. (NYSE: HIMS).…

Hims & Hers Health (HIMS) Is About to Report Q2 Earnings. Here’s What to Expect

Hims Hers Health ($HIMS) is scheduled to announce its results for the second quarter of 2025 after the market…

Shareholders of Hims & Hers Health, Inc. (HIMS): Protect Your Rights Before August 25, 2025 - Contact Levi & Korsinsky

ACCESS Newswire is the leading global press release distribution service. Tell your story and reach millions of journalists. Contact us…

Levi & Korsinsky Notifies Shareholders of Hims & Hers Health, Inc. (HIMS) of a Class Action Lawsuit and an Upcoming Deadline

NEW YORK, July 31, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Hims & Hers…

HIMS INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Hims & Hers Health, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

NEW YORK, July 31, 2025 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC, a nationally…

Can Sustained Product Demand Drive HIMS Stock Before Q2 Earnings?

Hims & Hers benefits from strong product demand and subscriber growth ahead of second-quarter 2025 earnings, fueled by weight loss…

Can Sustained Product Demand Drive HIMS Stock Before Q2 Earnings?

Hims & Hers Health, Inc. HIMS is scheduled to report second-quarter 2025 results on Aug. 4, after the closing bell.In…

Can Sustained Product Demand Drive HIMS Stock Before Q2 Earnings?

Hims & Hers benefits from strong product demand and subscriber growth ahead of second-quarter 2025 earnings, fueled by weight loss…

Hims & Hers Health, Inc. (HIMS) is Attracting Investor Attention: Here is What You Should Know

Hims & Hers Health (HIMS) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise…

The Gross Law Firm Notifies Hims & Hers Health, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline

NEW YORK, July 30, 2025 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders…

Hims & Hers Health, Inc. (HIMS) Alleged “Deceptive” Marketing of Wegovy® Triggers Securities Class Actions Investors with Losses Encouraged to Contact Hagens Berman

SAN FRANCISCO, July 30, 2025 (GLOBE NEWSWIRE) -- On June 25, 2025, securities class action lawsuits were filed…

HIMS INVESTORS: Hims & Hers Health, Inc. (NYSE:HIMS) Investors may have been Affected by Fraud – Contact BFA Law by August 25 about Potentially Recovering Losses

Hims & Hers Health, Inc. investors that lost money are notified to contact BFA Law before the August 25, 2025…

HIMS & HERS HEALTH SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuits Against Hims & Hers Health, Inc.

NEW YORK and NEW ORLEANS, July 29, 2025 (GLOBE NEWSWIRE) -- Kahn Swick & Foti, LLC (“KSF”) and…

HIMS Investors Have Opportunity to Lead Hims & Hers Health, Inc. Securities Fraud Lawsuit

/PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Hims &…

Hims & Hers Shows Personalized GLP-1 Plans Are Driving Real Results

New internal data suggests that Hims & Hers tailored weight loss model is improving outcomes and helping patients stick with…

Hims & Hers stock pares losses on data despite Novo Nordisk litigation fears By Investing.com

Hims & Hers stock pares losses on data despite Novo Nordisk litigation fears…

Hims & Hers stock pares losses on data despite Novo Nordisk litigation fears By Investing.com

Hims & Hers stock pares losses on data despite Novo Nordisk litigation fears…

INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Hims & Hers Health

/PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Hims & Hers…

Kampf um den GLP-1-Markt: Novo stürzt ab – Hims trotzt der Klageandrohung

Novo Nordisk verliert über 20?% nach Gewinnwarnung – Hims wird indirekt beschuldigt, Marktanteile abzugraben. Juristische Schritte angekündigt, doch…

Hims & Hers reports 10.3% weight loss in customers using GLP-1 treatments By Investing.com

Hims & Hers reports 10.3% weight loss in customers using GLP-1 treatments…

Hims & Hers reports 10.3% weight loss in customers using GLP-1 treatments By Investing.com

Hims & Hers reports 10.3% weight loss in customers using GLP-1 treatments…

Hims & Hers releases new data on GLP-1s

Hims Hers released new data showing that its personalized, digital-first approach to weight loss is driving results, laying the…

Hims & Hers Data Shows Personalized GLP-1 Plans Drive Real Weight Loss, Few Side Effects, and Strong Adherence to Care

Hims & Hers Health, Inc. (“Hims & Hers”, NYSE: HIMS), the leading health and wellness platform, today released new data…

Levi & Korsinsky Reminds Hims & Hers Health, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of August 25, 2025

/PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Hims & Hers Health, Inc. ("Hims & Hers Health, Inc." or…

Levi & Korsinsky Reminds Hims & Hers Health, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of August 25, 2025

NEW YORK, July 29, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Hims & Hers Health, Inc. ("Hims…

dpa-AFX ProFeed